Cargando…
LncRNA LINC01116 Contributes to Cisplatin Resistance in Lung Adenocarcinoma [Retraction]
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363395/ https://www.ncbi.nlm.nih.gov/pubmed/37489157 http://dx.doi.org/10.2147/OTT.S430432 |
Ejemplares similares
-
LncRNA LINC01116 Contributes to Cisplatin Resistance in Lung Adenocarcinoma
por: Wang, Junbin, et al.
Publicado: (2020) -
Silencing of LINC01116 Suppresses the Development of Oral Squamous Cell Carcinoma by up-Regulating microRNA-136 to Inhibit FN1 [Retraction]
Publicado: (2022) -
Retracted: LINC01116 Promotes Migration and Invasion of Oral Squamous Cell Carcinoma by Acting as a Competed Endogenous RNA in Regulation of MMP1 Expression
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023) -
Identification of an EMT-related lncRNA signature and LINC01116 as an immune-related oncogene in hepatocellular carcinoma
por: Tao, Haisu, et al.
Publicado: (2022) -
LncRNA LINC01116 Promotes Cancer Cell Proliferation, Migration And Invasion In Gastric Cancer By Positively Interacting With lncRNA CASC11
por: Su, Xiaohui, et al.
Publicado: (2019)